Evermil 20MG Tablet (10’s) is a pharmaceutical product containing Everolimus, a potent immunosuppressant and anti-cancer agent. This medication is primarily used in the treatment of various types of cancers, including renal cell carcinoma, and is also indicated for patients who have undergone organ transplants to prevent rejection. Evermil works by inhibiting the mTOR (mammalian target of rapamycin) pathway, which plays a crucial role in cell growth, proliferation, and survival. Each tablet contains 20 mg of Everolimus, and it is essential for patients to follow their healthcare provider’s instructions regarding its use. The drug is available in a blister pack of 10 tablets, making it convenient for patients to manage their treatment regimen. Evermil is recognized for its effectiveness in controlling tumor growth and improving the quality of life for patients with specific malignancies, as well as for its role in maintaining organ transplant success.